Ed Wolf: "I’m so over all the hoopla about Trump's first 100 days; I’d rather celebrate and acknowledge more important events..."
Photo of hospital bed from the internet
Day 149. The Big Bed
There were times on the AIDS ward, during the worst days of the epidemic, when several patients died on the same day. Broken-hearted lovers and friends and family members would circle the bed and weep as their beloveds departed. There were other days when everyone was well enough to be discharged and live another day. As soon as the bed was available, someone else would be admitted. Sometimes, when there was an empty bed, a docto
From The Conversation, guest author Laura Bisaillon on rampant HIV discrimination through the immigration process.
Are you kidding me? With nearly four decades under our collective belts of global experience working on HIV and AIDS, we are past considering it acceptable to link someone’s health status with their perceived sexual “moral values.”
Such were my thoughts after reading and reflecting on an article in The Toronto Star this month: “Decision-maker slammed as ‘Moral Police’ for refusing immigration to HIV-positive man.”
I have researched medical inadmissibility decision-making and
From Overland, guest author Daniel Reeders: "... messages on sexual health almost invariably focus on sex rather than health."
Image credit: Reginald Mount, ‘The easy girlfriend’ (poster), Norwich: Her Majesty’s Stationery Office, 1943-44. This file comes from Wellcome Images, a website operated by Wellcome Trust, a global charitable foundation based in the United Kingdom. Refer to Wellcome blog post (archive).
This article by Daniel Reeders previously appeared at Overland, here.
Two or three times a year, there’ll be a major conference on sexual health, or a report released on how many new sexually tr
Indigenous, Latino, bisexual and single men less likely to be aware of newly publicly-funded HIV prevention medication
(Vancouver, January 31, 2018) A new study shows most of gay, bi, men who have sex with men (MSM) and other MSM, are aware of PrEP (pre-exposure prophylaxis) - an HIV prevention drug recently made available at no charge to British Columbians at risk of HIV - according to the Momentum Health Study at the BC Centre for Excellence in HIV/AIDS.
“Gay, bisexual, MSM and other MSM in Canada accounted for 56.8% of all new cases of HIV in Canada,” says research scientist, Nathan Lachowsky. “Incre
"CATIE expresses our solidarity with Toronto’s LGBT, South Asian and Middle Eastern communities, and we extend our support to efforts to change the way community concerns are addressed in the future."
The staff and board of directors of CATIE were deeply distressed to learn about the deaths of Selim Esen, Andrew Kinsman, Majeed Kayhan, Soroush Mahmudi and Dean Lisowick. We extend our condolences to the families and friends of the victims and our colleagues at the Toronto HIV/AIDS Network and the Toronto People With AIDS Foundation, where Andrew Kinsman worked and volunteered.
We also offer our support for the Alliance for South Asian AIDS Prevention, which has called for an external review
Closures have taken place across central London and remaining clinics across the capital are facing unmanageable demands. From the Evening Standard, Eleanor Rose reports.
Testing: Digital services will allow people to carry out tests at home, but the rollout has been delayed.
To read the complete story by Eleanor Rose, visit The Evening Standard, here.
Up to 600 people per week are being turned away from oversubscribed sexual health clinics at one of London’s NHS trusts, an expert has warned. Dr Mark Lawton of the British Association of Sexual Health and HIV said the data showing hundreds of people are being turned away from clinic at Guy’s and St Tho
The breadth of data being collected is intended to help answer the wide range of questions about what “real-world” PrEP use looks like in the province. Jack Mohr of the Ontario PrEP Cohort Study has this report.
After years spent waiting, more widespread access to Pre-Exposure Prophylaxis (PrEP) in Ontario finally seems to be taking shape. Health Canada approval for generic forms of tenofovir disoproxil fumarate/emtricitabine (the drug combination used for PrEP) has drastically decreased out of pocket costs for PrEP. This development, along with concerted lobbying from HIV activists, also led to the addition of PrEP to the Ontario Drug Benefit formulary in September 2017. While these changes don’t
From the National Institutes of Health: NIH clinical trial is testing antibody against the protein in people with HIV.
For the first time, scientists have shown a relationship between the proportion of key immune cells that display high levels of a gut-homing protein called alpha-4 beta-7 at the time of HIV infection and health outcomes. Previous research illustrated this relationship in monkeys infected with a simian form of HIV.
The new study found that women who had more CD4+ T cells displaying high levels of alpha-4 beta-7 on their surface were more likely to become infected with HIV, and the virus damage
The Global U=U picture is good, but community activists are stepping up the heat on organizations which have been slow to embrace it. Today the spotlight is on Greater than AIDS, GNP+ and in Canada, the Ontario AIDS Network. Bob Leahy reports.
This article originallly appeared on January 16, 2018
If 2017 was a good year for many people living with HIV, it was for a simple, three character slogan that seemed to be everywhere. POZ.com, in awarding Undetectable equals Untransmittable, or U=U, the campaign of the year described it as “perhaps the most discussed and rapidly shared message to hit the HIV arena in years”. The Washington Post called it “the campaign credited with beginning to change public perception of HIV trans
Toxicity and patient factors were the main reasons why women did not receive treatment recommended in guidelines.From AIDSmap, Michael Carter reports.
The majority of HIV-positive women diagnosed with gynaecological cancer do not receive treatment recommended by cancer guidelines, according to research conducted in the United States and published in AIDS. Women whose care did not match guideline standards had poorer survival compared to women who received the recommended care. Toxicity and patient factors were the main reasons why women did not receive treatment recommended in guidelines.
“To our knowledge, there is no case series de
Please sign this petition calling for GIPA to be acknowledged in HIV research findings
The partnerships forged between people living with HIV and researchers have been an essential foundation upon which the response to the HIV epidemic has grown and the time has come to reaffirm and recommit to principles of inclusion and respect in the conduct of presenting research findings that impacts on our lives.
The early years of the HIV epidemic ushered in a radically different approach to traditional medical and clinical research. Academics and activists held a shared understanding th
Hear an update of how Toronto can end HIV transmissions.
Leading Toronto researchers and clinicians invite you to a discussion of how HIV prevention tools are improving and combine to get us to zero new infections.
(Speakers: Sharmistha Mishra, Rupert Kaul, Malika Sharma, Beth Rachlis, Taylor Sicard, Isaac Bogoch, Abigail Kroch. Moderator: R. Reinhard)
When: Wednesday, February 7, 2018 6:30-8:30 PM
Where: Hart House Music Room (U. of Toronto campus)
Elevator and access ramp accessible. Light refreshments will be provided.
Please RVSP by email
From The Conversation, Dennis Altman: "Desire, behaviour and identity are distinct, and do not always overlap."
This article by Dennis Altman prevously appeared at The Conversation, here.
The rise of sexually transmissible diseases made front-page news in The Age, which tried to make sense of the rise among “gay men” and “heterosexual people”.
This illustrates the increasingly common confusion between behaviour and identity. What is involved is sexual contact, or to use the expression common in the early days of the AIDS epidemic, “the exchange of bodily fluids”. Whether people involve
Varenicline (combined with counselling) can clearly help some HIV-positive people to quit smoking. From CATIE, Sean R. Hosein reports.
- People living with HIV are known to be at increased risk for smoking-related illnesses.
- Researchers find varenicline safe and effective at helping people with HIV quit smoking.
- Cessation counsellors who are infectious disease specialists have higher quit rates.
The widespread use of potent HIV treatment (ART) has led to improved measures of health and near-normal life expectancy for many people with HIV in Canada and other high-income countries. However, studies have found that ART us